Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant

Pediatric Infectious Disease Journal

Volumn 28, Issue 1, 2009, Pages 55-57

  Faraci, Maura ^a   Cuzzubbo, Daniela ^a   Lanino, Edoardo ^a   Di Marco, Eddi ^b   Cirillo, Carmela ^b   Dallorso, Sandro ^a   Morreale, Giuseppe ^a   Moroni, Cristina ^c   Castagnola, Elio ^c  

^a Department of Haematology and Oncology   (Italy)

^b Experimental and Clinical Medicine Laboratory   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

BK virus; cidofovir; hemorrhagic cystitis; probenecid

Indexed keywords

CIDOFOVIR; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; PROBENECID; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BK VIRUS; CHILD; CLINICAL ARTICLE; CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; FANCONI ANEMIA; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMORRHAGIC CYSTITIS; HUMAN; LOW DRUG DOSE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ANTIVIRAL AGENTS; BK VIRUS; CHILD; CHILD, PRESCHOOL; CYSTITIS; CYTOSINE; DRUG ADMINISTRATION SCHEDULE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; PHOSPHONIC ACIDS; POLYOMAVIRUS INFECTIONS; PROBENECID; TUMOR VIRUS INFECTIONS;

EID: 66149101543     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181812cb9     Document Type: Article

References (14)

1. Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008;41:11-18.
2. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003;3:611-623.
3. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995;13:1103-1109.
4. Vats A, Randhawa PS, Shapiro R. Diagnosis and treatment of BK virus-associated transplant nephropathy. Adv Exp Med Biol. 2006;577:213-227.
5. Barouch DH, Faquin WC, Chen Y, et al. BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis. 2002;35:326-329.
6. Peinemann F, de Villiers EM, Dorries K, et al. Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr. 2000;159:182-188.
7. Savona MR, Newton D, Frame D, et al. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant. 2007;39:783-787.
8. Araya CE, Lew JF, Fennell RS III, et al. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant. 2006;10:32-37.
9. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant. 2006;10:920-922.
10. Kadambi PV, Josephson MA, Williams J, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant. 2003;3:186-191.
11. Kubista M, Andrade JM, Bengtsson M, et al. The real-time polymerase chain reaction. Mol Aspects Med. 2006;27:95-125.
12. Hayden FG. Antiviral drugs (other than antiretrovirals). In: Mandell GL, Bennett JE, Doolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Churchill Livingstone; 2005:514-550.
13. Gorczynska E, Turkiewicz D, Rybka K, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:797-804.
14. Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis. 2005;45:804-817.